Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA approval of Alzheimer's drug Aduhelm 'rife with irregularities,' House report says By: FOX Business December 30, 2022 at 11:21 AM EST A report by two House committees found that the Food and Drug Administration's controversial approval of the Alzheimer's drug Aduhelm was "rife with irregularities." Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA approval of Alzheimer's drug Aduhelm 'rife with irregularities,' House report says By: FOX Business December 30, 2022 at 11:21 AM EST A report by two House committees found that the Food and Drug Administration's controversial approval of the Alzheimer's drug Aduhelm was "rife with irregularities." Read More >>